Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Genera and Dechra Pharmaceuticals Manufacturing. It manufactures and markets Companion Animal, Equine and Food producing Animal Products. It includes third party manufacturing and other non-core activities sales. The NA Pharmaceuticals Segment consists of Dechra Veterinary Products US, Putney, Dechra Veterinary Products Canada, and Dechra-Brovel that sell Companion Animal and Equine Products into those territories. The Pharmaceuticals Research and Development Segment includes its pharmaceutical research and development activities. Its offerings include Osphos and Vetoryl.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:DPH
- CUSIP: N/A
- Web: N/A
Capitalization:- Market Cap: £1.7 billion
- Outstanding Shares: 92,818,000
Average Prices:- 50 Day Moving Avg: GBX 1,713.43
- 200 Day Moving Avg: GBX 1,511.30
- 52 Week Range: GBX 811 - GBX 1,851
P/E:- Trailing P/E Ratio: 120.00
- P/E Growth: 1.65
Sales & Book Value:- Annual Revenue: £309.39 million
- Price / Sales: 5.51
- Book Value: GBX 3.08 per share
- Price / Book: 5.96
Profitability:Misc:- Average Volume: 161,947 shs.
Frequently Asked Questions for Dechra Pharmaceuticals plc (LON:DPH)
What is Dechra Pharmaceuticals plc's stock symbol?
Dechra Pharmaceuticals plc trades on the London Stock Exchange (LON) under the ticker symbol "DPH."
How often does Dechra Pharmaceuticals plc pay dividends? What is the dividend yield for Dechra Pharmaceuticals plc?
Dechra Pharmaceuticals plc declared a dividend on Monday, February 27th. Investors of record on Thursday, March 9th will be given a dividend of GBX 6.11 per share on Friday, April 7th. This represents a dividend yield of 0.38%. The ex-dividend date of this dividend is Thursday, March 9th. The official announcement can be seen at this link. View Dechra Pharmaceuticals plc's Dividend History.
Where is Dechra Pharmaceuticals plc's stock going? Where will Dechra Pharmaceuticals plc's stock price be in 2017?
6 brokerages have issued twelve-month price objectives for Dechra Pharmaceuticals plc's stock. Their predictions range from GBX 1,140 to GBX 1,890. On average, they expect Dechra Pharmaceuticals plc's stock price to reach GBX 1,576.43 in the next twelve months. View Analyst Ratings for Dechra Pharmaceuticals plc.
Who are some of Dechra Pharmaceuticals plc's key competitors?
Some companies that are related to Dechra Pharmaceuticals plc include Hiscox Ltd (HSX), IMI plc (IMI), BBA Aviation plc (BBA), Derwent London Plc (DLN), Playtech PLC (PTEC), Iwg Plc (IWG), Spectris plc (SXS), Metro Bank PLC (MTRO), Phoenix Group Holdings (PHNX), Howden Joinery Group Plc (HWDN), John Wood Group PLC (WG), UBM Plc (UBM), EVRAZ plc (EVR), Capital & Counties Properties PLC (CAPC), Shaftesbury plc (SHB), Daily Mail and General Trust plc (DMGT), Tp Icap Plc (TCAP) and Renishaw plc (RSW).
How do I buy Dechra Pharmaceuticals plc stock?
Shares of Dechra Pharmaceuticals plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Dechra Pharmaceuticals plc stock cost?
One share of Dechra Pharmaceuticals plc stock can currently be purchased for approximately GBX 1,836.
Consensus Ratings for Dechra Pharmaceuticals plc (LON:DPH) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | 3 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.50) |
| Consensus Price Target: | GBX 1,576.43 |
Analysts' Ratings History for Dechra Pharmaceuticals plc (LON:DPH)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 4/20/2017 | Panmure Gordon | Reiterated Rating | Under Review | |  |
| 4/4/2017 | Numis Securities Ltd | Boost Price Target | Add | GBX 1,700 -> GBX 1,890 | |
| 4/4/2017 | Stifel Nicolaus | Boost Price Target | Hold | GBX 1,440 -> GBX 1,550 | |
| 3/14/2017 | Royal Bank of Canada | Boost Price Target | Outperform | GBX 1,630 -> GBX 1,890 | |
| 3/1/2017 | Jefferies Group LLC | Boost Price Target | Hold | GBX 1,320 -> GBX 1,565 | |
| 2/27/2017 | N+1 Singer | Reiterated Rating | Buy | GBX 1,600 | |
| 2/24/2017 | FinnCap | Reiterated Rating | Under Review | | |
| 9/5/2016 | Investec | Boost Price Target | Buy | GBX 1,300 -> GBX 1,400 | |
| 9/7/2015 | Shore Capital | Reiterated Rating | Buy | | |
(Data available from 5/24/2015 forward)
Earnings History for Dechra Pharmaceuticals plc (LON:DPH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Dechra Pharmaceuticals plc (LON:DPH)Current Year EPS Consensus Estimate: $62.33 EPS
Dividend History by Quarter for Dechra Pharmaceuticals plc (LON:DPH)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/27/2017 | | GBX 6.11 | 0.38% | 3/9/2017 | 3/9/2017 | 4/7/2017 |
| 9/5/2016 | | GBX 12.91 | 0.92% | 10/27/2016 | 10/27/2016 | 11/18/2016 |
| 2/22/2016 | | GBX 5.55 | 0.47% | 3/10/2016 | 3/10/2016 | 4/6/2016 |
| 9/7/2015 | | GBX 11.82 | 1.26% | 10/29/2015 | 10/29/2015 | 11/20/2015 |
| 9/8/2014 | | GBX 10.65 | 1.4% | 11/6/2014 | 11/6/2014 | 11/21/2014 |
| 2/25/2014 | | GBX 4.75 | 0.68% | 3/12/2014 | 3/12/2014 | 4/8/2014 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Dechra Pharmaceuticals plc (LON:DPH)Insider Trades by Quarter for Dechra Pharmaceuticals plc (LON:DPH)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/2/2017 | Ian Page | Insider | Sell | 1,630 | GBX 1,715 | £27,954.50 | |
| 3/21/2017 | Tony Griffin | Insider | Sell | 3,500 | GBX 1,676 | £58,660 | |
| 11/30/2016 | Tony Griffin | Insider | Sell | 17,133 | GBX 1,292 | £221,358.36 | |
| 6/3/2016 | Rice,Tony | Insider | Buy | 20,000 | GBX 1,141 | £228,200 | |
| 3/21/2016 | Nesmes,Anne-Francoise | Insider | Sell | 3,100 | GBX 1,208 | £37,448 | |
| 9/9/2015 | Nesmes,Anne-Francoise | Insider | Sell | 18,319 | GBX 940 | £172,198.60 | |
(Data available from 1/1/2013 forward)
Headline Trends for Dechra Pharmaceuticals plc (LON:DPH)
Latest Headlines for Dechra Pharmaceuticals plc (LON:DPH)
| Source: |
|
Dechra Pharmaceuticals plc (DPH) Chart for Wednesday, May, 24, 2017
